GlassScriptPhysician profile
Jameel C Uddeen
NPI 1669767059
$17,540.72
in general payments reported to CMS, 2019-2025
49 companies · $4,304 in 2025
The $4,304 reported for 2025 was more than what 87% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,223 · 2020: $975 · 2021: $1,555 · 2022: $2,395 · 2023: $2,709 · 2024: $3,381 · 2025: $4,304.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Education: $36.10.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,357.71 |
| Education | $36.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $3,441.91 | 2019-2025 | Tezspire, Fasenra, Breztri |
| Glaxosmithkline, LLC. | $3,147.19 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,478.47 | 2019-2025 | Spiriva Respimat, Stiolto Respimat, Ofev |
| Takeda Pharmaceuticals U.S.A., INC. | $1,191.00 | 2022-2025 | Glassia, Hyqvia |
| Genzyme Corporation | $1,011.52 | 2019-2025 | |
| Amgen INC. | $957.01 | 2022-2025 | Tezspire, Uplizna |
| Regeneron Healthcare Solutions, INC. | $720.74 | 2019-2025 | Dupixent |
| Mylan Specialty L.P. | $620.62 | 2019-2024 | Yupelri |
| Novartis Pharmaceuticals Corporation | $553.69 | 2019-2024 | |
| Grifols USA, LLC | $447.86 | 2021-2025 | Prolastin-C Liquid |
| Genentech USA, INC. | $402.93 | 2019-2025 | Xolair |
| Inspire Medical Systems, INC. | $366.56 | 2023-2025 | Inspire |
| Electromed, INC. | $333.80 | 2019-2025 | Smartvest |
| Verona Pharma, INC. | $305.22 | 2025 | Ohtuvayre |
| Baxter Healthcare | $274.53 | 2023-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System, Hillrom - Monarch Airway Clearance System |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $232.79 | 2019-2025 | Vest Therapy Und, (O58) Sleep Respiratory Care Und, (Ak6) Vest Therapy |
| Viatris Specialty LLC | $217.67 | 2025 | Yupelri |
| Pfizer INC. | $175.08 | 2019-2025 | |
| Optinose US, INC. | $163.97 | 2025 | |
| Mallinckrodt Hospital Products INC. | $160.60 | 2020-2025 | Terlivaz, Acthar |
| Covis Pharma Gmbh | $139.14 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $111.27 | 2019-2024 | Keytruda |
| W. L. Gore & Associates, INC. | $105.54 | 2019 | |
| Mallinckrodt Enterprises LLC | $95.11 | 2019 | |
| Aerin Medical INC. | $86.86 | 2025 | |
| Janssen Pharmaceuticals, INC | $62.94 | 2019-2023 | Xarelto |
| Pulmonx Corporation | $54.57 | 2021-2025 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
| Sunovion Pharmaceuticals INC. | $52.92 | 2019 | |
| Vifor Pharma, INC. | $49.03 | 2024-2025 | Zemaira |
| Paratek Pharmaceuticals, INC. | $47.64 | 2023-2024 | Nuzyra |
| 3b Medical, INC. | $45.33 | 2025 | Luna |
| Shockwave Medical, INC | $41.04 | 2022 | |
| Gilead Sciences, INC. | $38.86 | 2021 | |
| Alexion Pharmaceuticals, INC. | $38.24 | 2019 | |
| Seqirus USA INC | $34.87 | 2019-2025 | Fluad, Flucelvax |
| Teva Pharmaceuticals USA, INC. | $34.52 | 2021 | |
| Tanabe Pharma America, INC. | $34.38 | 2019-2023 | |
| Actelion Pharmaceuticals US, INC. | $33.81 | 2025 | Opsumit |
| Fisher & Paykel Healthcare INC | $32.08 | 2019 | |
| Phadia US INC. | $32.05 | 2022 | |
| Csl Behring | $27.34 | 2024 | Haegarda |
| Neurocrine Biosciences, INC. | $26.03 | 2019 | |
| Azurity Pharmaceuticals, INC. | $21.57 | 2025 | Alvesco |
| Abbvie INC. | $18.00 | 2024 | |
| Ani Pharmaceuticals, INC. | $16.65 | 2025 | Purified Cortrophin Gel |
| Circassia INC. | $16.33 | 2019 | |
| Ambu INC. | $14.37 | 2024 | |
| Insmed, INC. | $13.74 | 2024 | Arikayce |
| Watermark Medical, INC. | $13.33 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jameel Uddeen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.